Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8622976 | 8480443 | F | 8622976-9 | 20120301 | 20120823 | 20120827 | EXP | PHHY2012MT025421 | NOVARTIS PHARMACEUTICAL CORPORATION | YR | M | Y | 20120827 | MD | MALTA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8622976 | 1020667875 | SS | CLOZAPINE | 1 | ORAL | 019758 | |||||
| 8622976 | 1020667874 | PS | CLOZAPINE | 1 | ORAL | 300 MG, BID | 019758 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8622976 | 1020667874 | SCHIZOPHRENIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8622976 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 8622976 | HAEMOGLOBIN DECREASED |
| 8622976 | IRON DEFICIENCY ANAEMIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8622976 | 1020667875 | 20120701 | |||
| 8622976 | 1020667874 | 20070101 | 20120301 |